{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:26:28Z","timestamp":1779207988028,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["L70DA061529"],"award-info":[{"award-number":["L70DA061529"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["U01DA51658"],"award-info":[{"award-number":["U01DA51658"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["T32DA031115"],"award-info":[{"award-number":["T32DA031115"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["UG3DA057850"],"award-info":[{"award-number":["UG3DA057850"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["F32DA063281"],"award-info":[{"award-number":["F32DA063281"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA031115"],"award-info":[{"award-number":["T32DA031115"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["L70DA061529"],"award-info":[{"award-number":["L70DA061529"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA51658"],"award-info":[{"award-number":["U01DA51658"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AQ-0039"],"award-info":[{"award-number":["AQ-0039"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.dadr.2025.100365","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:48:55Z","timestamp":1753202935000},"page":"100365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A humanized monoclonal antibody attenuates carfentanil self-administration in nonhuman primates"],"prefix":"10.1016","volume":"16","author":[{"given":"Lindsey K.","family":"Galbo-Thomma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Baehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine A.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5157-6307","authenticated-orcid":false,"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2025.100365_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.121.001048","article-title":"Pharmacological profiling of antifentanyl monoclonal antibodies in combination with naloxone in pre- and postexposure models of fentanyl toxicity","volume":"381","author":"Baehr","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.dadr.2025.100365_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43126-0","article-title":"Investigation of monoclonal antibody CSX-1004 for fentanyl overdose","volume":"14","author":"Bremer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dadr.2025.100365_bib3","unstructured":"Centers for Disease Control and Prevention, 2024. U.S. Overdose Deaths Decrease in 2023, First Time Since 2018. NCHS. \u3008https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm\u3009 (Accessed 18 April 2025)."},{"key":"10.1016\/j.dadr.2025.100365_bib4","unstructured":"Cessation Therapeutics, Inc., 2024. A Phase 1a, Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of CSX-1004 Injection in Healthy Adults (Clinical Trial Registration No. NCT06005402). \u3008https:\/\/wwwclinicaltrials.gov\u3009.\u3008https:\/\/www.clinicaltrials.gov\u3009.."},{"key":"10.1016\/j.dadr.2025.100365_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100365_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/cpt.2098","article-title":"Countermeasures for preventing and treating opioid overdose","volume":"109","author":"France","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.dadr.2025.100365_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-025-06751-9","article-title":"A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys","author":"Galbo-Thomma","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.dadr.2025.100365_bib8","series-title":"Drug Overdose Deaths in the United States, 2003-2023. NCHS Data Brief, No 522","author":"Garnett","year":"2024"},{"key":"10.1016\/j.dadr.2025.100365_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2122507","article-title":"Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development","volume":"18","author":"Hicks","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.dadr.2025.100365_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151995","article-title":"In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice","volume":"770","author":"Hoppe","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.dadr.2025.100365_bib11","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/add.15260","article-title":"Carfentanil and the rise and fall of overdose deaths in the United States","volume":"116","author":"Jalal","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2025.100365_bib12","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1038\/s41598-022-09601-2","article-title":"Naloxone\u2019s dose-dependent displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain","volume":"12","author":"Kang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.dadr.2025.100365_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13543784.2023.2187286","article-title":"The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis","volume":"32","author":"Martinez","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.dadr.2025.100365_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed in the synthetic opioid era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"10.1016\/j.dadr.2025.100365_bib15","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"2010"},{"key":"10.1016\/j.dadr.2025.100365_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.dadr.2025.100365_bib17","doi-asserted-by":"crossref","first-page":"42506","DOI":"10.1021\/acsomega.4c06617","article-title":"Structure-based engineering of monoclonal antibodies for improved binding to counteract the effects of fentanyl and carfentanil","volume":"9","author":"Rodarte","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.dadr.2025.100365_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100365_bib19","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7348a2","article-title":"Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths \u2014 United States, 2021\u20132024","volume":"73","author":"Tanz","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2025.100365_bib20","doi-asserted-by":"crossref","first-page":"a039263","DOI":"10.1101\/cshperspect.a039263","article-title":"Medications development for treatment of opioid use disorder","volume":"11","author":"Townsend","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:11:18Z","timestamp":1772921478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":20,"alternative-id":["S2772724625000484"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100365","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A humanized monoclonal antibody attenuates carfentanil self-administration in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100365"}}